The DiaSorin company announced it has completed tests at Pavia’s Policlinico San Matteo Hospital and the necessary studies to launch a new high-volume serum test to detect antibodies in patients infected with COVID-19.
The company said it is working to get the CE label and authorization for emergency use (EUA) from the Food and Drug Administration before the end of April.
